NCT05078424

Brief Summary

The proposed study is a randomized controlled trial (RCT) that aims to examine the effectiveness of cognitive behavioural therapy in reducing depressive and anxiety symptoms for youths in Hong Kong. It is to be carried out with 120 youths aged 12 - 24 recruited from a series of community-based LevelMind@JC hubs, funded by the Hong Kong Jockey Club Charities Trust. It is designed to improve the youths' abilities/ skills in handling moods to have better emotional management. A written informed consent will be signed by participants. Researchers will perform cognitive behavioural therapy on youths who agree to join the study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2021

Completed
23 days until next milestone

Study Start

First participant enrolled

September 29, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 14, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

October 14, 2021

Status Verified

September 1, 2021

Enrollment Period

2.6 years

First QC Date

September 6, 2021

Last Update Submit

September 30, 2021

Conditions

Keywords

Randomized Controlled TrialCognitive Behavioural TherapyYouthsDepressive and Anxiety Symptoms

Outcome Measures

Primary Outcomes (7)

  • Change in depressive and anxiety levels

    Depression Anxiety Stress Scales (DASS), scores ranging from 0-42 for each subscale, with higher scores representing worse outcome

    Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

  • Change in social anxiety levels

    Social Interaction Anxiety Scale (SIAS), scores ranging from 0-80 with higher scores representing higher levels of social anxiety hence worse outcome

    Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

  • Change in depressive levels

    Patient Health Questionnaire-9 (PHQ-9), scores ranging from 0-27 with higher scores representing higher depressive levels hence worse outcome

    Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

  • Change in distress levels

    Kessler Psychological Distress Scale (K6), scores ranging from 0-25 with higher scores representing higher distress hence worse outcome

    Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

  • Change in depressive symptoms

    Beck Depression Inventory II (BDI-II), scores ranging from 0-63 with higher scores representing severe depressive symptoms hence worse outcome

    Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

  • Change in anxiety symptoms

    Beck Anxiety Inventory (BAI), scores ranging from 0-36 with higher scores representing severe anxiety symptoms hence worse outcome

    Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

  • Change in anxiety levels

    Generalized Anxiety Stress Scale-7 (GAD-7), scores ranging from 0-21 with higher scores representing higher anxiety levels hence worse outcome

    Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Secondary Outcomes (8)

  • Change in functioning

    Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

  • Change in social and occupational functioning

    Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

  • Change in quality of life

    Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

  • Change in self-harm

    Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

  • Change in resilience

    Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

  • +3 more secondary outcomes

Study Arms (2)

CBT Treatment group

EXPERIMENTAL

This group receives CBT interventions that aim to improve mental well-being, depressive and anxiety symptoms in young people.

Behavioral: Cognitive Behavioural Therapy

Wait-list Control group

NO INTERVENTION

This group does not receive CBT intervention but will receive appropriate intervention after the CBT treatment group and follow-up phases complete.

Interventions

CBT is a well-established, evidence-based intervention frequently used for easing depressive and anxiety symptoms. The intervention will be delivered for 6-7 sessions, each session lasts for 1.5 hours, in the format of a group for a period of 6-7 weeks by frontline social or youth workers trained by professional CBT clinicians. Core treatment components include mood monitoring, emotion education, behavioural activation, emotion cycle/ ABC model, identification of automatic thoughts, and cognitive restructuring. It is designed to improve youths' abilities/ skills in handling their moods to have better emotional management.

CBT Treatment group

Eligibility Criteria

Age12 Years - 24 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • LevelMind@JC users with mild to moderate distress level (n=120);
  • have sufficient proficiency in Chinese to understand verbal instructions and give informed consent;

You may not qualify if:

  • known diagnosis of intellectual disability
  • organic brain disorder
  • photosensitive epilepsy
  • significant visual, auditory or balance impairment
  • current or previous use of illicit drugs
  • known psychiatric diagnosis (stabilized diagnosis and treatment)
  • receiving any psychosocial treatment for social withdrawal such as CBT or;
  • current or active suicidal ideation or attempts.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychiatry, The University of Hong Kong

Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

DepressionAnxiety Disorders

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Central Study Contacts

Eric Yu Hai Chen, FHKAM (Psychiatry)

CONTACT

Christy Lai Ming Hui, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chair Professor

Study Record Dates

First Submitted

September 6, 2021

First Posted

October 14, 2021

Study Start

September 29, 2021

Primary Completion

April 30, 2024

Study Completion

April 30, 2024

Last Updated

October 14, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations